JNJ-64619178
CAS: 2086772-26-9
Rif. 3D-LID77226
| 1mg | 252,00 € | ||
| 2mg | 370,00 € | ||
| 5mg | 527,00 € | ||
| 10mg | 753,00 € | ||
| 25mg | 1.121,00 € |
Informazioni sul prodotto
JNJ-64619178 is a novel small molecule that targets the methyltransferase domain of the protein PRMT5. The compound has been shown to induce apoptosis in cancer cells, and is currently being evaluated for safety and efficacy in clinical trials. This drug has been shown to have a favorable safety profile and shows no adverse effects on erythropoiesis. JNJ-64619178 is an investigational drug that belongs to the class of compounds that bind to the target site on PRMT5, which is involved in regulating gene expression. It binds to enzymes with methyltransferase activity and inhibits RNA splicing, leading to cell death by apoptosis.
Proprietà chimiche
Richiesta tecnica su: 3D-LID77226 JNJ-64619178
Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.
